(GBT) - Earnings & Price History

GBT: - 38.85, $1.73B, -0.95 (-2.39%)

Sector: Healthcare - Industry: Biotechnology

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is headquartered in South San Francisco, California.Key Statistics

Past GBT reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2016-11-10AMC-0.5819.5518.7518.7518.419.64.27%4.27%697.71K
2016-03-29BMO-0.5614.5412.9912.9412.2414.85-0.38%12.36%11.93%299.58K
2015-11-12-3.0541.7643.6643.5140.643.58-0.34%▲-4.02%-4.35%175.06K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades